MK0752 in Treating Young Patients With Recurrent or Refractory CNS Cancer

This study has been terminated.
(This Phase I study was permanently closed to patient accrual on February 23, 2011, due to the discontinuation of support from MERCK.)
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Pediatric Brain Tumor Consortium
ClinicalTrials.gov Identifier:
NCT00572182
First received: December 11, 2007
Last updated: March 2, 2012
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: February 2011
  Primary Completion Date: February 2011 (Final data collection date for primary outcome measure)